|
|||||
|
|
Long‐term safety and tolerability of oral tofacitinib in patients with Crohn’s disease: results from a phase 2, open‐label, 48‐week extension study |
|
| Authors: | Juli n Pan s,Geert R. D&#x Haens,Peter D. R. Higgins,Linda Mele,Michele Moscariello,Gary Chan,Wenjin Wang,Wojciech Niezychowski,Chinyu Su,Eric Maller |
| Affiliation: | Julián Panés,Geert R. D’Haens,Peter D. R. Higgins,Linda Mele,Michele Moscariello,Gary Chan,Wenjin Wang,Wojciech Niezychowski,Chinyu Su,Eric Maller |
| Abstract: | |
| Keywords: | |